---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-241940"
form_type: "8-K"
ticker: "CATX"
cik: "0000728387"
company_name: "Perspective Therapeutics, Inc."
filed_at: "2026-05-27T20:20:15+00:00"
generated_at: "2026-05-27T20:23:26.406672+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Perspective Therapeutics announces 2026 annual meeting voting results; all director nominees elected

## Summary
- Elected all six director nominees: Woods, Henson, Martinez-Davis, Morich, Spoor, Williamson.
- Ratified WithumSmith+Brown as independent auditor for FY2026 with 97.6M votes for.
- Non-binding advisory vote favored annual say-on-pay; Board adopts 1-year frequency.
- 97,882,462 shares (85.85% of outstanding) represented at meeting, forming quorum.

## SEC filing metadata
- accession: 0001193125-26-241940
- form_type: 8-K
- ticker: CATX
- cik: 0000728387
- company_name: Perspective Therapeutics, Inc.
- filed_at: 2026-05-27T20:20:15+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/728387/000119312526241940/0001193125-26-241940-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/728387/000119312526241940/catx-20260527.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-241940
- JSON: https://secwatch.observer/filing/0001193125-26-241940.json
- Plain text: https://secwatch.observer/filing/0001193125-26-241940.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.